- Q1 2024 BioArctic AB Earnings Call TranscriptMay 17, 2024kr230.2 (-0.78%)Earnings
- Q4 2023 BioArctic AB Earnings Call TranscriptFeb 14, 2024kr217.2 (+8.17%)Earnings
- Q3 2023 BioArctic AB Earnings Call TranscriptNov 08, 2023kr213 (-1.75%)Earnings
- Q2 2023 BioArctic AB Earnings Call TranscriptJul 12, 2023kr291.4 (+0.48%)Earnings
- Q1 2023 BioArctic AB Earnings Call TranscriptApr 27, 2023kr254 (+8.55%)Earnings
- Q4 2022 BioArctic AB Earnings Call TranscriptFeb 03, 2023kr297.4 (-1.78%)Earnings
- Q3 2022 BioArctic AB Earnings Call TranscriptOct 20, 2022kr250 (+4.60%)Earnings
- Q2 2022 BioArctic AB Earnings Call TranscriptJul 12, 2022kr78.35 (-3.15%)Earnings
- Q1 2022 BioArctic AB Earnings Call TranscriptApr 28, 2022kr74.3 (-6.54%)Earnings
- Q4 2021 BioArctic AB Earnings Call TranscriptFeb 03, 2022kr110.2 (-1.25%)Earnings
- Q3 2021 BioArctic AB Earnings Call TranscriptOct 21, 2021kr143.8 (-1.64%)Earnings
- Q2 2021 BioArctic AB Earnings Call TranscriptJul 09, 2021kr145.2 (+4.91%)Earnings
- Q1 2021 BioArctic AB Earnings Call TranscriptApr 21, 2021kr92.6 (+2.66%)Earnings
- Full Year 2020 BioArctic AB Earnings Call TranscriptFeb 04, 2021kr99.8 (-0.70%)Earnings
- Nine Months 2020 BioArctic AB Earnings Call TranscriptOct 14, 2020kr88.45 (+1.43%)Earnings
- Q2 2020 BioArctic AB Earnings Call TranscriptJul 10, 2020kr80.55 (+7.69%)Earnings
- Q1 2020 BioArctic AB Earnings Call TranscriptApr 22, 2020kr64.4 (-7.07%)Earnings
- Full Year 2019 BioArctic AB Earnings Call TranscriptFeb 06, 2020kr82.65 (-3.22%)Earnings
- Q3 2019 BioArctic AB Earnings Call TranscriptOct 24, 2019kr92.5 (+1.82%)Earnings
- Q2 2019 BioArctic AB Earnings Call TranscriptJul 11, 2019kr71.7 (-0.42%)Earnings
- Q1 2019 BioArctic AB Earnings Call TranscriptMay 09, 2019kr75.5 (+0.47%)Earnings
- Full Year 2018 BioArctic AB Earnings Call TranscriptFeb 14, 2019kr97.75 (+2.79%)Earnings
Q3 2019 BioArctic AB Earnings Call Transcript
Hello, and welcome to the BioArctic Q3 Report 2019. (Operator Instructions)
Today, I'm pleased to present CEO, Gunilla Osswald; and CFO, Jan Mattsson. So please go ahead with your meeting.
()-
Welcome to BioArtic's interim report from January to September. I'm Gunilla Osswald and I'm the CEO of BioArtic, and I'm happy to do the presentation here today and share it with our CFO, Jan Mattsson.
Next slide, please. This is our disclaimer. And BioArtic is listed on NASDAQ.com midcap.
Next slide, please. For those of you who are new to BioArtic, I will start with a short introduction to the company. And BioArtic is a unique Swedish biopharma company. By that, I put it into 4 different areas. I start with that we are working on areas where there is a high unmet medical need in CNS. Today, there are only symptomatic treatments for Alzheimer's disease and Parkinson's disease and we focus on disease-modifying treatments, and these are areas where there is a growing
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)